Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Laura Loy"'
Publikováno v:
Nutrients, Vol 16, Iss 8, p 1108 (2024)
Accumulating evidence from pre-clinical and clinical studies demonstrate the benefit of dietary fibers for inflammatory bowel disease (IBD). However, the majority of patients avoid or limit their consumption to manage their symptoms during the active
Externí odkaz:
https://doaj.org/article/191a649b2ba540fa8d9c367a9842d00f
Autor:
Giulia Migliorisi, Giovanna Vella, Arianna Dal Buono, Roberto Gabbiadini, Anita Busacca, Laura Loy, Cristina Bezzio, Paolo Vinciguerra, Alessandro Armuzzi
Publikováno v:
Cells, Vol 13, Iss 2, p 142 (2024)
Background and aims: Inflammatory bowel diseases (IBD) are multifactorial chronic inflammatory disorders affecting the gastrointestinal tract. However, a broad spectrum of extraintestinal manifestations (EIMs) is associated with IBD, affecting severa
Externí odkaz:
https://doaj.org/article/d9c0f41371f14f1ba55d1d685555ba22
Autor:
Giulia Rizzo, Samuel Elias Pineda Chavez, Elisa Vandenkoornhuyse, Cindy Lorena Cárdenas Rincón, Valeria Cento, Valentina Garlatti, Marek Wozny, Giusy Sammarco, Alessia Di Claudio, Lisa Meanti, Sudharshan Elangovan, Andrea Romano, Giulia Roda, Laura Loy, Arianna Dal Buono, Roberto Gabbiadini, Sara Lovisa, Roberto Rusconi, Alessandro Repici, Alessandro Armuzzi, Stefania Vetrano
Publikováno v:
Nutrients, Vol 15, Iss 7, p 1771 (2023)
Background: Pomegranate (Punica granatum) can be used to prepare a bioactive extract exerting anti-inflammatory activities. Clinical studies demonstrated an improvement in clinical response in inflammatory bowel disease (IBD) patients when pomegranat
Externí odkaz:
https://doaj.org/article/72a1b9b8dee940e0816329f970e88076
Autor:
Virginia Solitano, Ferdinando D’Amico, Mariangela Allocca, Gionata Fiorino, Alessandra Zilli, Laura Loy, Daniela Gilardi, Simona Radice, Carmen Correale, Silvio Danese, Laurent Peyrin-Biroulet, Federica Furfaro
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
The potential of endoscopic evaluation in the management of inflammatory bowel diseases (IBD) has undoubtedly grown over the last few years. When dealing with IBD patients, histological remission (HR) is now considered a desirable target along with s
Externí odkaz:
https://doaj.org/article/1b5708e3d00b4e318efc7f0e805b15a6
Autor:
Gionata Fiorino, Federica Furfaro, Alessandra Zilli, Giulia Roda, Laurent Peyrin-Biroulet, Mariangela Allocca, Laura Loy, Simona Radice, Daniela Gilardi, Silvio Danese
Publikováno v:
Current Drug Targets. 22:370-378
The increasing armamentarium of drugs for inflammatory bowel disease (IBD) requires a direct comparison of different therapeutic options in order to guide physicians in the choice of the most appropriate treatment for their patients. Head-to-head tri
Autor:
Daniela Gilardi, Federica Furfaro, Roberto Gabbiadini, Alessandra Zilli, Mariangela Allocca, Gionata Fiorino, Laurent Peyrin-Biroulet, Laura Loy, Silvio Danese, Giulia Roda, Eirini Zacharopoulou, Vincenzo Craviotto
Publikováno v:
Current Drug Targets. 22:347-355
Background: Intestinal fibrosis and subsequent strictures represent an important burden in inflammatory bowel disease (IBD). Both the detection and evaluation of the degree of fibrosis in stricturing Crohn’s disease (CD) are important when deciding
Autor:
Laura Loy
Publikováno v:
Cerveau & Psycho. :64-69
Autor:
Gionata Fiorino, Carmen Correale, Federica Furfaro, Eirini Zacharopoulou, Marjorie Argollo, Daniela Gilardi, Silvio Danese, Laura Loy, Alessandra Zilli, Mariangela Allocca, Edoardo Vespa
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 14:829-841
Crohn's disease (CD) and ulcerative colitis (UC) are immune-mediated disorders characterized by a chronic inflammation, with intermittent exacerbations of symptoms and inflammation. In both diseases, medical treatment has made revolutionary steps for
Publikováno v:
World Journal of Gastroenterology
Background Smoking has detrimental effects on Crohn's disease (CD) activity while data on ulcerative colitis (UC) are conflicting. Little is known about the use and impact of alternative smoking products in inflammatory bowel diseases (IBD). Aim To u
Autor:
Mariangela Allocca, Virginia Solitano, Ferdinando D'Amico, Giulia Roda, Laura Loy, Silvio Danese, Federica Furfaro, Laurent Peyrin-Biroulet, Alessandra Zilli, Gionata Fiorino
Publikováno v:
Expert Review of Gastroenterology & Hepatology. 14:765-773
Introduction: Several biological drugs and a new small molecule are available for the treatment of Crohn's disease and ulcerative colitis. However, to date, no reliable predictors of response to treatment have yet been identified. Areas covered: We f